STRR
Star Equity Holdings, Inc.
There isn't enough reported data to score STRR yet.
STRR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Strong |
STRR's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
STRR PE Valuation
STRR has no meaningful PE right now: it lost money over the past year.
STRR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for STRR, with profitability improving. However, they disagree widely on these estimates.
STRR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.50 | — |
| Q3 2026 | -$2.43 | -$0.86 |
| Q2 2026 | -$2.54 | -$1.23 |
| Q1 2026 | -$2.27 | -$1.04 |
| Q4 2025 | -$1.85 | -$0.26 |
| Q3 2025 | -$1.57 | -$0.43 |
| Q2 2025 | -$1.31 | -$0.62 |
| Q1 2025 | -$1.23 | -$0.87 |
| Q4 2024 | -$1.59 | -327% |
STRR lost $2.43 per share over the past year, a bigger loss than the year before.
STRR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $53.9M | +12% |
| Q2 2026 | $54.9M | +55% |
| Q1 2026 | $50.1M | +57% |
| Q4 2025 | $56.8M | +69% |
| Q3 2025 | $48M | +30% |
| Q2 2025 | $35.5M | -0.5% |
| Q1 2025 | $31.9M | -6% |
| Q4 2024 | $33.6M | -1.1% |
STRR's revenue has grown year over year for five quarters in a row: $54M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.4% | +0.1 points |
| Q2 2026 | -2.5% | -1.9 points |
| Q1 2026 | -8% | -2.6 points |
| Q4 2025 | -0.2% | +0.2 points |
| Q3 2025 | -3.4% | -2.2 points |
| Q2 2025 | -0.6% | -0.1 points |
| Q1 2025 | -5.4% | +3.6 points |
| Q4 2024 | -0.4% | +3.4 points |
STRR's operating margin was −3.4% last quarter, about level with the same quarter a year ago.
STRR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60K | +$3.4M |
| Q2 2026 | -$3.2M | -3269% |
| Q1 2026 | -$2.7M | -$1.9M |
| Q4 2025 | -$4.9M | -342% |
| Q3 2025 | -$3.4M | -368% |
| Q2 2025 | $102K | +$4.4M |
| Q1 2025 | -$808K | +$986K |
| Q4 2024 | $2M | -39% |
STRR's free cash flow was −$11M over the past year, against −$2M the year before.
STRR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -7.9x | Net Cash |
| Q3 2023 | -4.6x | Net Cash |
| Q2 2023 | -4.9x | Net Cash |
| Q1 2023 | -2.9x | Net Cash |
| Q4 2022 | -2.4x | Net Cash |
| Q3 2022 | -1.7x | Net Cash |
| Q2 2022 | -1.9x | Net Cash |
| Q1 2022 | -2.0x | Net Cash |
STRR has more cash than debt.
STRR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.3 | Neutral |
| Stochastic | 26.2 | Neutral |
STRR's weekly RSI is 48 (neutral) and its Stochastic is 26 (neutral).
STRR PE vs Healthcare Sector
| Metric | STRR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
STRR has no meaningful PE right now: it lost money over the past year.
STRR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.84 | 1.6% above |
| 20 week MA | $10.3 | 2.9% below |
| 50 week MA | $10.3 | 3.1% below |
| 100 week MA | $10.4 | 3.6% below |
| 200 week MA | $14.2 | 30% below |
STRR has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 30% below its 200-week average.
STRR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.5 | $10.7 | -14% |
| 2021 | $10.7 | $27.4 | +155% |
| 2022 | $27.4 | $23.5 | -14% |
| 2023 | $23.5 | $15.5 | -34% |
| 2024 | $15.5 | $13.4 | -14% |
| 2025 | $13.4 | $10.9 | -18% |
| 2026 YTD | $10.9 | $10.0 | -8.4% |
STRR has finished four years in a row lower, and it's down 8.4% so far in 2026.